Given the strong association between high expression of S100A8 in the primary and metastatic lesion in animal models, we hypothesized that breast cancer with a high S100A8 expression score is also associated with a worse prognosis of survival and associated with clinical parameters with aggressive breast cancers. Here, S100A8 is linked to breast carcinoma.